About Intact Vascular
Intact Vascular is a company based in Wayne (United States) founded in 2011 was acquired by Philips in August 2020. Intact Vascular has raised $123.4 million across 10 funding rounds from investors including Philips, Runway Growth Capital and Vensana Capital. Intact Vascular offers products and services including Vascular Suite, Azurion 7 M20, and Sonicare Toothbrush. Intact Vascular operates in a competitive market with competitors including Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
- Headquarter Wayne, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Intact Vascular, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intact Vascular
Intact Vascular offers a comprehensive portfolio of products and services, including Vascular Suite, Azurion 7 M20, and Sonicare Toothbrush.
Supports vascular procedures with real-time guidance and imaging tools.
Ceiling-mounted system for flexible peripheral and aneurysm procedures.
Electric toothbrush for improved oral health and cleaning.
Funding Insights of Intact Vascular
Intact Vascular has successfully raised a total of $123.4M across 10 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $30 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Intact Vascular
Intact Vascular has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Philips, Runway Growth Capital and Vensana Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in medical technology are made by Vensana Capital.
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Intact Vascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intact Vascular
Investment portfolio details for Intact Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intact Vascular
Detailed financials for Intact Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intact Vascular Comparisons
Peer comparison for Intact Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intact Vascular
Intact Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| Locked | Locked | Locked |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| Locked | Locked | Locked |
Innovative medical devices for peripheral vessel treatment are developed.
|
|
| Locked | Locked | Locked |
Devices for removing vascular blockages are developed.
|
|
| Locked | Locked | Locked |
Smart devices are provided to clear peripheral arterial blockages.
|
Detailed competitors of Intact Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intact Vascular
Complete news archive for Intact Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intact Vascular
Intact Vascular was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Intact Vascular is headquartered in Wayne, United States.
Intact Vascular is a funded company, having raised a total of $123.4M across 10 funding rounds to date.
Intact Vascular was founded in 2011 as a privately held medical device company located in Wayne, United States. Minimally invasive peripheral vascular products are developed by the company to address peripheral artery disease. The Tack Endovascular System, a metal implant, is utilized to repair arterial dissections that occur following angioplasty procedures. Approval has been granted by the FDA, and the CE mark has been received for the device.
Intact Vascular's top competitors include Avinger, Okami Medical and Cagent Vascular.
Intact Vascular offers Vascular Suite, Azurion 7 M20, and Sonicare Toothbrush.
Intact Vascular has 6 investors. Key investors include Philips, Runway Growth Capital, Vensana Capital, NEA, and HIG BioHealth Partners.